Infrequent laboratory abnormalities during terbinafine therapy for onychomycosis: A retrospective cohort analysis within an integrated health system.

Wenk, Kurt S; Wu, Xinxie; Miller, Michael J

Wenk, Kurt S; Wu, Xinxie; Miller, Michael J.

Afiliação

Wenk KS; Department of Dermatology, Mid-Atlantic Permanente Medical Group, Springfield, Virginia. Electronic address: kurt.s.wenk@kp.org.
Wu X; Mid-Atlantic Permanente Medical Group, Rockville, Maryland.
Miller MJ; Mid-Atlantic Permanente Medical Group, Rockville, Maryland; Mid-Atlantic Permanente Research Institute, Rockville, Maryland.

J Am Acad Dermatol ; 2023 Sep 15.

Article em En | MEDLINE | ID: mdl-37717727

Palavras-chave

abnormality; aminotransferase; cohort; drug-induced liver injury; hepatotoxicity; infrequent; laboratory; monitoring; onychomycosis; retrospective; terbinafine

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies Idioma: En Revista: J Am Acad Dermatol Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google